About
Basic Data Updated:
24 days agoBDR Pharmaceuticals International Private Limited is a renowned company that specializes in the manufacturing of APIs (Active Pharmaceutical Ingredients). The company's wide range of products is divided into three categories: intermediates, APIs, and finished formulations. These products are used in the production of various medicines and treatments. The intermediates produced by BDR Pharmaceuticals include adapalene, nebivolol hydrochloride, irbesartan, and etoricoxib, among others. These are essential components in the production of high-quality medicines. The company's API segment comprises of antibacterial (betalactum), glycopeptide, quinolone, and various other APIs. These are crucial in the development of effective treatments for various diseases. BDR Pharmaceuticals also offers a range of finished formulations, including pegylated liposomal, oncology products, gyneacology products, higher range antibiotics, and lyophilized injectables. These products are manufactured in the company's two API facilities located in Gujarat and two formulation facilities in Gujarat and Uttarakhand. Additionally, the company has a state-of-the-art pellet facility in Hyderabad. The company's products are not only popular in India but are also exported to Africa, Asia, Europe, North America, and South America.
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | U24230MH2002PTC137329 |
| Company No. | 137329 |
| Company Classification | Private Limited Indian Non-Government Company |
| Incorporation Date | 24 Sep 2002 |
| Date of AGM | 29 Dec 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Mumbai |
Financials of Bdr Pharmaceuticals International Private Limited
Bdr Pharmaceuticals International Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 35.19% decrease. The company also saw a substantial fall in profitability, with a 46.45% decrease in profit. The company's net worth Soared by an impressive increase of 38.6%.
Corporate Structure
Unlock access to Bdr Pharmaceuticals International's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Bdr Pharmaceuticals International Private Limited
Unlock and access historical data on people associated with Bdr Pharmaceuticals International, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (2)
AB
Anand Bagaria CFOStatus: Current
PS
Pinky Shah
Company SecretaryStatus: Current
Board Members(6)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Abn Amro Bank N. V. Creation Date: 15 Mar 2006 | ₹9.00 Cr | Satisfied |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bdr Pharmaceuticals International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bdr Pharmaceuticals International's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Spinos Life Science And Research Private Limited
Active
8 years 1 month Raheel Shah and Aravind Badiger are mutual person
Bdr Lifesciences Private Limited
Active 30 years 7 months Tejash Shah and Raheel Shah are mutual person
Recent activity within the organization
Annual General Meeting
Bdr Pharmaceuticals International Private Limited last Annual general meeting of members was held on 29 Dec 2023 as per latest MCA records.
29 Dec 2023Balance Sheet
Bdr Pharmaceuticals International Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
31 Mar 2023Director Appointment
Dharmesh Mahendra Shah was appointed as a Director was appointed as a Director on 13 May 2022 & has been associated with this company since 2 years 7 days .
13 May 2022Director Appointment
Manish Gaur was appointed as a Nominee Director was appointed as a Nominee Director on 12 May 2022 & has been associated with this company since 2 years 8 days .
12 May 2022Charges
A charge registered on 15 Mar 2006 via Charge ID 80015564 with Abn Amro Bank N. V. was fully satisfied on 22 Jan 2019.
22 Jan 2019
Recent News, Updates & Announcement
BDENZA The GameChanging Oral Solution for Prostate Cancer Patients.When you have prostate cancer but dont want to deal with nausea from meds try BDENZA oral solution Its gentle on the stomach sugarfree and tastes good Plus its only one small serving instead of lots of pills Doctors can adjust the dose for each patient and its affordable BDR Pharma is changing the game with this patientfriendly solution.
IndiaMedToday 04 Jan 2024
- XAVITAZ The Ultimate Solution for GramNegative Infections by BDR Pharma 2g Ceftazidime 500mg Avibactam Combo.
When you need to fight off those pesky gramnegative infections just remember XAVITAZ a powerful combo of 2g Ceftazidime 500mg Avibactam Brought to you by BDR Pharmaceuticals to make sure everyone has access to topnotch treatment Lets keep those RD efforts going and help people stay healthy XAVITAZ BDRPharma GramNegativeInfections PowerCombo.
IndiaMedToday 30 Jan 2023
- engageBDR secures additional capital for growth opportunities.
Tech Capital 30 Jan 2019
- Carlyle likely to invest 100 M in BDR Pharma.
BioSpectrum India 14 Aug 2018
Frequently asked questions
What is the Incorporation or founding date of Bdr Pharmaceuticals International Private Limited?
